Compare INAB & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INAB | BBGI |
|---|---|---|
| Founded | 2016 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 11.5M |
| IPO Year | 2020 | 1999 |
| Metric | INAB | BBGI |
|---|---|---|
| Price | $0.82 | $5.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 35.4K | 18.1K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 48.01 |
| Revenue | N/A | ★ $232,179,463.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.47 |
| P/E Ratio | ★ N/A | $0.12 |
| Revenue Growth | N/A | ★ 69.89 |
| 52 Week Low | $0.80 | $3.14 |
| 52 Week High | $2.73 | $29.30 |
| Indicator | INAB | BBGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.98 | 26.88 |
| Support Level | N/A | $3.50 |
| Resistance Level | $1.50 | $24.70 |
| Average True Range (ATR) | 0.08 | 0.63 |
| MACD | -0.01 | 0.25 |
| Stochastic Oscillator | 2.00 | 22.27 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
Beasley Broadcast Group Inc is a multi-platform media company whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA; Augusta, GA; Boston, MA; Charlotte, NC; Detroit, MI; Fayetteville, NC; Fort Myers-Naples, FL; Las Vegas, NV; Middlesex, NJ; Monmouth, NJ; Morristown, NJ; Philadelphia, PA; Tampa-Saint Petersburg, FL; and Wilmington, DE. The company operates in two segments: Audio, which generates the maximum revenue, and Digital.